Market revenue in 2023 | USD 85.1 million |
Market revenue in 2030 | USD 132.1 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Other vaccines |
Fastest growing segment | Modified/ Attenuated Live |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines |
Key market players worldwide | Boehringer Ingelheim, CEVA Inc, Zoetis, Elanco Animal Health Inc, Merck & Co Inc, Phibro Animal Health Corp Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to poultry vaccines market will help companies and investors design strategic landscapes.
Other vaccines was the largest segment with a revenue share of 41.6% in 2023. Horizon Databook has segmented the France poultry vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the France poultry vaccines market , including forecasts for subscribers. This country databook contains high-level insights into France poultry vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account